Suchergebnisse - "Zanaletti, Nicoletta"

PubPharm (21)

1

Codon-specific KRAS mutations predict survival benefit of trifluridine/tipiracil in metastatic colorectal cancer

enthalten in: Nature medicine | 2023

von van de Haar, J. | Ma, X. | Ooft, S. | +47

CommentIn: Nat Rev Gastroenterol Hepatol. 2023 May;20(5):269. - PMID 37012321

2

Heterogeneous disease and intermittent treatment in metastatic colorectal cancer : A case report

enthalten in: Frontiers in oncology | 2023

von De Stefano, A. | Zanaletti, N. | Cassata, A. | +11

3

Adjuvant chemotherapy after neoadjuvant chemo-radiotherapy and surgery in locally advanced rectal cancer. A systematic review of literature with a meta-analysis of randomized clinical trials

enthalten in: Critical reviews in oncology/hematology | 2022

von Tamburini, E. | Tassinari, D. | Ramundo, M. | +12

4

A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen : is there room for improvement?

enthalten in: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer | 2022

von Antonetti, P. | Fargnoli, M. | Porzio, G. | +27

5

Clinicians' Attitude to Doublet Plus Anti-EGFR Versus Triplet Plus Bevacizumab as First-line Treatment in Left-Sided RAS and BRAF Wild-Type Metastatic Colorectal Cancer Patients : A Multicenter, "Real-Life", Case-Control Study

enthalten in: Clinical colorectal cancer | 2021

von Parisi, A. | Porzio, G. | Cannita, K. | +36

6

A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?

enthalten in: Supportive care in cancer | 2021

von Antonetti, P. | Fargnoli, M. | Porzio, G. | +27

7

A multicenter study of skin toxicity management in patients with left-sided, RAS/BRAF wild-type metastatic colorectal cancer treated with first-line anti-EGFR-based doublet regimen: is there room for improvement?

enthalten in: Supportive care in cancer | 2021

von Antonetti, P. | Fargnoli, M. | Porzio, G. | +27

8

Cetuximab Rechallenge Plus Avelumab in Pretreated Patients With RAS Wild-type Metastatic Colorectal Cancer : The Phase 2 Single-Arm Clinical CAVE Trial

enthalten in: JAMA oncology | 2021

von Martinelli, E. | Martini, G. | Famiglietti, V. | +27

9

Retrospective Study of Regorafenib Versus TAS-102 Efficacy and Safety in Chemorefractory Metastatic Colorectal Cancer (mCRC) Patients : A Multi-institution Real Life Clinical Data

enthalten in: Clinical colorectal cancer | 2021

von Vitale, P. | Zanaletti, N. | Famiglietti, V. | +12

10

Immunotherapy may protect cancer patients from SARS-CoV-2 infection : a single-center retrospective analysis

enthalten in: Journal of translational medicine | 2021

von Isgrò, M. | Vitale, M. | Celentano, E. | +20